N. Snoeren, R. van Hillegersberg, S. B. Schouten, A. Bergman, E. van Werkhoven, O. Dalesio, R. Tollenaar, H. Verheul, J. V. D. van der Sijp, I. B. Borel Rinkes, E. Voest
{"title":"评估加或不加贝伐单抗佐剂CAPOX在结直肠癌肝转移切除术后患者中的疗效和安全性的随机III期研究:肝细胞癌研究12","authors":"N. Snoeren, R. van Hillegersberg, S. B. Schouten, A. Bergman, E. van Werkhoven, O. Dalesio, R. Tollenaar, H. Verheul, J. V. D. van der Sijp, I. B. Borel Rinkes, E. Voest","doi":"10.1016/j.neo.2016.08.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18888,"journal":{"name":"Neoplasia (New York, N.Y.)","volume":"17 1","pages":"93 - 99"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"18","resultStr":"{\"title\":\"Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study12\",\"authors\":\"N. Snoeren, R. van Hillegersberg, S. B. Schouten, A. Bergman, E. van Werkhoven, O. Dalesio, R. Tollenaar, H. Verheul, J. V. D. van der Sijp, I. B. Borel Rinkes, E. Voest\",\"doi\":\"10.1016/j.neo.2016.08.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18888,\"journal\":{\"name\":\"Neoplasia (New York, N.Y.)\",\"volume\":\"17 1\",\"pages\":\"93 - 99\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"18\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neoplasia (New York, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.neo.2016.08.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia (New York, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.neo.2016.08.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study12